Format

Send to

Choose Destination
ACS Appl Mater Interfaces. 2017 Dec 27;9(51):44293-44306. doi: 10.1021/acsami.7b13643. Epub 2017 Dec 13.

Cu(II)-Doped Polydopamine-Coated Gold Nanorods for Tumor Theranostics.

Author information

1
State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University , Changchun 130012, P. R. China.
2
School of Materials Science and Engineering, Qingdao University , Qingdao 266071, P. R. China.

Abstract

Gold nanorods (AuNRs) are potentially useful in tumor theranostics, but the poor stability, high toxicity, and rapid removal by the immune system seriously limit their theranostic applications. In our study, we demonstrate the fabrication of Cu(II)-doped polydopamine-coated AuNR (AuNR@CuPDA), which significantly improves the potentials in tumor theranostics. Besides the improvement of physiological stability and biocompatibility, the PDA shell increases the photothermal performance and prolongs the blood circulation time of AuNRs. The half-life of AuNRs during blood circulation increases from 0.7 to 4.5 h after PDA coating, and the injected dose per gram of tumor tissue is 4.6% ID g-1 for AuNR@CuPDA. In addition to computer tomography imaging, the loading of Cu(II) in PDA shell endows AuNR@CuPDA with magnetic resonance imaging function. Cu(II) doped in PDA shell also exhibits chemotherapeutic behavior, and the tumor inhibitor rate is 31.2%. Further combining 808 nm laser-driven photothermal therapy, tumors were completely ablated, and no recurrence was observed. Liver and renal functions tests and histological analysis of major organs confirm that AuNR@CuPDA is in good safety.

KEYWORDS:

computer tomography imaging; gold nanorods; magnetic resonance imaging; polydopamine; thermo-chemotherapy; tumor theranostics

PMID:
29235846
DOI:
10.1021/acsami.7b13643
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center